Tag Archives: Docetaxel

Australia: Docetaxel case

[Bloomberg] The interlocutory petition for restraining generic launch of Docetaxel in Australia is denied by federal judge. Docetaxel product per se is protected by patent no AU591309 (expiry: Feb 06, 2011) and composition is protected by patent no AU666859 (expiry: July 2012). … Continue reading

Posted in Patent case | Tagged , , , | Leave a comment

CI & Patent News: 29/11/2010

1)  Actavis launches Docetaxel single vial on patent expiry in major European markets (Press Release) …. launched by Actavis under its own brand in Germany, the Netherlands, UK and Sweden, as well as by Medis ― the company’s sales division … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , | Leave a comment